Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Nektar Therapeutics (NKTR): Q2 EPS of -$0.30 beats by $0.03. Revenue of $23.7M (+36.6% Y/Y)...

  • Thursday, August 9, 2012, 4:44 PM ET
    Nektar Therapeutics (NKTR): Q2 EPS of -$0.30 beats by $0.03. Revenue of $23.7M (+36.6% Y/Y) beats by $4M. (PR)
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Earnings Articles
More Latest Articles »